LabCorp wins FDA clearance for at-home COVID-19 test

By LabPulse.com staff writers

April 21, 2020 -- LabCorp has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Pixel by LabCorp COVID-19 at-home test kit. The kit is the first to be approved by the FDA for self-collection of samples by patients at home.

The test kit can now be used by individuals to self-collect nasal swab specimens at home if recommended by a healthcare provider after completion of a COVID-19 questionnaire, according to LabCorp. Offered through the company's Pixel by LabCorp platform, the kits will initially be available to healthcare workers and first responders who may have been exposed to COVID-19 or may be symptomatic.

Consumers will be able to access the COVID-19 self-collection kits in the coming weeks, the vendor said.


Copyright © 2020 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?